Physician profile
Andrea Bernadette Martin
NPI 1679012827
$531.71
in general payments reported to CMS, 2019-2025
12 companies · $182 in 2025
The $182 reported for 2025 was more than what 92% of Neonatal (Nurse Practitioner) providers received nationally (typical 2025 total: $40.24).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $52.53 · 2022: $65.70 · 2023: $119 · 2024: $112 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $413.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $105.70 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $68.07 | 2024-2025 | Xifaxan |
| Currax Pharmaceuticals LLC | $59.28 | 2022-2023 | Contrave |
| Bausch Health US, LLC | $57.73 | 2025 | Aplenzin |
| Bolton Medical INC | $52.53 | 2021 | |
| Lundbeck LLC | $50.17 | 2025 | Vyepti, Rexulti |
| Ardelyx, INC. | $32.15 | 2024-2025 | Ibsrela |
| Conmed Corporation | $29.67 | 2024 | Visiclear |
| Collegium Pharmaceutical, INC. | $23.23 | 2025 | Jornay Pm |
| Optinose US, INC. | $19.93 | 2022 | |
| Azurity Pharmaceuticals, INC. | $17.39 | 2025 | Azmiro |
| Almatica Pharma LLC | $15.86 | 2024 | Loreev Xr, Teriparatide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.